Article
Health Plans,
Forum,
Article,
Mental Health,
Employers
Why EAP utilization is low and how employers are addressing it
The mounting popularity of GLP-1 therapies is changing how people—and the healthcare system—address type 2 diabetes and obesity care. We'll explore the opportunities and risks of these therapies and examine the role of these medications in the long-term management of two of the costliest conditions organizations face.